BJP Evidence-Based Mental Health
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


The British Journal of Psychiatry (1963) 109: 399-403. doi: 10.1192/bjp.109.460.399
© 1963 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WHITWAM, J. G.
Right arrow Articles by NORMAN, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WHITWAM, J. G.
Right arrow Articles by NORMAN, J.

Clinical Signs with Modified Electroconvulsive Therapy

J. G. WHITWAM M.B., F.F.A.R.C.S.1, T. MORETON M.A., M.B., B.Chir.2, and J. NORMAN M.B.3

1 Senior Registrar, Department of Anaesthetics, General Infirmary at Leeds
2 Registrar, Department of Psychiatry, University of Leeds
3 Registrar, Department of Anaesthetics, The General Infirmary at Leeds

A technique for modified E.C.T. is described, together with some clinical observations on skeletal muscle movements, pupil changes, respiration, eyelash reflex and the timing of the various events.

The authors describe two clinical signs which are of value in the management of therapy. Firstly, the cessation of fasciculation in the muscles controlling the feet can be used as a means of assessing the time of optimum relaxation following suxamethonium. Secondly, abolition of the pupillary light reflex can be used to assess the effectiveness of the shock in producing a convulsion.

Using atropine 0.65 mg. subcutaneously 30 minutes prior to therapy, convulsive activity of the pupils was observed during the clonic phase. This activity was reduced with an increase in dose of atropine to 0.9 mg. subcutaneously 30 minutes prior to therapy, and was either further reduced or abolished when a change was made to intravenous atropine > (1 mg.) immediately prior to therapy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1963 The Royal College of Psychiatrists.